FPT-EUROPE
FPT Europe, a subsidiary of the global technology services provider FPT Corporation, has announced the collaboration with innogy Czech, a leading energy company providing natural gas, electricity and heating solutions, as well as clean mobility solutions, to migrate the innogy Czech’s entire SAP R/3-based ERP infrastructure to the SaaS cloud. As the general contractor of the project, FPT will support the customer to migrate the current system to SAP S/4HANA as part of the greenfield approach. The goal is thus a complete redesign of the Enterprise Resource Planning (ERP), which is business-critical for innogy Czech, including streamlining and simplifying all processes automated in the system. FPT is responsible for the entire scope of the project, from consulting to planning and implementation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210817005685/en/
"We entrusted FPT with the upgrade of our SAP system to S/4 HANA because of the company’s expertise, technical capabilities and years of experience in the industry," says Miloš Dušek, Senior Manager of Corporate Applications at innogy Ceska republika. "The project is of great strategic importance for innogy. FPT has proven to be a reliable strategic partner for us and has put together a qualified team to ensure that the first part of the project will be delivered successfully by the end of 2021."
Lighthouse project in the growing market of SAP S/4HANA
The aim of the project is to replace the current SAP ERP system used by innogy Czech in version R/3 ERP Central Component 6.0 EhP 8, which has so far been based on HANA DB2, with S/4HANA Private Cloud Edition. "SAP made an announcement that the company will end the support for its on-premises solutions by 2027. Many companies therefore would want to migrate their system to S/4 HANA in a timely manner," explains Andy Do, Deputy Director/Head of Delivery at FPT Europe. "FPT has strong expertise and many years of experience in cloud migration as well as SAP migration projects, but the project with innogy Czech can be considered as one of the largest end-to-end S/4HANA migration projects for us. It offers FPT a great opportunity to position ourselves as a trusted partner in the field of SAP S/4HANA migration."
The scope of work mentioned above will be applied for 5 companies within innogy Czech Republic group, including innogy Ceska republika a.s., innogy Zakaznicke sluzby, s.r.o., innogy Energie, s.r.o., innogy Energo, s.r.o. and innogy Energetika Plhov-Nachod, s.r.o.
FPT has more than 20 years of experience in providing services related to SAP. With a pool of more than 300 functional and 250 technical consultants, FPT has successfully implemented and rolled out SAP systems for customers in Southeast Asia, Japan and Europe. With SAP S/4HANA, FPT offers a wide range of services such as development, implementation and rollout. FPT also offers its own solutions in the field of Application Managed Services (AMS). FPT’s services in the areas of SAP migration, SAP customization, SAP rollout and SAP Automation Testing help its customers assure smooth and efficient implementation of SAP S/4HANA.
About FPT Europe
FPT Europe, based in Essen, Germany is a part of FPT Corporation - a technology and IT services provider headquartered in Vietnam with nearly US$2 billion in revenue and 36,000 employees. Being a pioneer in digital transformation, the company delivers world-class services in Smart factory, Digital platforms, RPA, AI, IoT, Data Analytics, Mobility, Cloud, Managed Services, Testing. FPT Software has served over 700 customers worldwide, 100 of which are Fortune 500 companies in the industries of Aerospace & Aviation, Automotive, Banking and Finance, Communications, Media and Services, Logistics & Transportation, Utilities, Consumer Packaged Goods, Healthcare, Manufacturing, Public sector, Technology and so on. Established in 2012, FPT Europe has become technology partners of 50 leading companies including Siemens, RWE, Allianz, Schaeffler, Airbus, Carlsberg and many more. For other information, please visit: www.fpt-europe.de
About innogy Czech
innogy Česká republika is a leading energy company in the Czech Republic owned by the largest Hungarian energy group MVM. innogy supplies 1.6 million customers with energy and energy-related innovative services. First class customer service is provided by own call centres and a chain of customer service centres. In addition to gas and electricity supplies, innogy produces heat and electricity in heating plants across the country with an annual heat production of 900,000 GJ. Aside from the core business, innogy focuses on clean mobility, photovoltaics and energy management services. With a nationwide network of 60+ filling stations, own CNG technology production and more than 10 million kg CNG sold annually, innogy is a strong market leader. innogy is also building up a solid position in the fast-growing solar power plants market. The company employs 1,500 highly skilled people and the innogy brand is known to more than 90% of the Czech population.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210817005685/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
